From Trials to Real-world Data: National Insights on Cladribine Tablets in Multiple Sclerosis After Four Years and Beyond (P8-1.009)
Year: 2025
Type: article
Study design: Observational Study
Source: Neurology
Authors: Dominika Stastna, Gregor Fistravec, Jiri Drahota, Ingrid Menkyova, Radek Ampapa, Pavel Potuznik, Michal Dufek, Marketa Grunermelova, Eva Kubala Havrdova, Jana Houskova, Jana Libertinova, Alena Martinkova, Zbysek Pavelek, Marek Peterka, Eva Recmanova, Zuzana Rous, Ivana Stetkarova, Pavel Stourac, Marta Vachova, Ivana Woznicova, Dana Horakova
Institutions: Charles University, General University Hospital in Prague, Hospital Jihlava, University Hospital Plzen, Masaryk University, St. Anne's University Hospital Brno, Thomayer University Hospital, Nemocnice České Budějovice, University Hospital in Motol, Pardubice Region, University Hospital Hradec Králové, University Hospital Olomouc, Palacký University Olomouc, University Hospital Kralovske Vinohrady, University Hospital Brno, University Hospital Ostrava
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409235661